NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hera Biotech

Hera Biotech

Private
San Antonio, TexasHealthcare & Life Scienceshttps://herabiotech.com/

Last Round

Series A

May 3, 2025

Total Funding Raised

$13.01M

Company Overview

Hera Biotech is a biotechnology company that develops non-surgical, tissue-based diagnostic tests for the detection and staging of endometriosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

endometriosis diagnosticmolecular diagnosticwomen's healthfemtechendometrial biopsyprecision medicineclinical diagnosticsmachine learning diagnosticsai-driven diagnosticsnon-surgical diagnosisreproductive endocrinologyclinical validationbiotechnologydiagnostic test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hera Biotech Comparables

Compare Hera Biotech with similar companies based on industry and business-model similarity.

Hera Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DotLab
87%
HerAnova Lifesciences
87%
EndoSure, Inc.
84%

Hera Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 3, 2025
SeedAug 24, 2022
GrantOct 20, 2021

Key People

Founding team and executive leadership

Somer Baburek

Co-Founder, CEO, President

Founding Team

Cinzia Donato

COO

Executive Team

Hera Biotech Investors

Notable investors and investment history

Hera Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hera Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hera Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Antonio, Texas
Employee Range12
Year Founded2020
Last FundingMay 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.